Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Investor Presentation

Sat Kartar Life Investor Presentation: Key Takeaways

H1 FY27 deck discloses no revenue, PAT or EBITDA figures. Balance sheet is debt-free with ₹18.7 Cr net cash. Growth is hospital-led: 30-bed Delhi unit at breakeven, 300 beds targeted by FY27-end.

Highlights
MarginsN/A; no margin figures disclosed.
Demand visibilityIndustry CAGRs cited; no company demand data.

Growth

No H1 FY27 revenue or profit numbers disclosed. Only past milestone cited: surpassed ₹50 Cr revenue in 2022.

Outlook

Target 300 beds by FY27-end; LOIs for Dehradun and Gurugram hospitals; US product range entry planned. No numeric revenue guidance.

Risks

No explicit risk section. Hospital capex rollout and new US/international expansion carry execution risk.

Source

Investor Presentation filed with NSE, NSE: SATKARTAR. Summary written with AI assistance from the document.

Read the document ↗

Sat Kartar Life Ltd: key numbers

Share price
₹130.35
Market cap
₹205.9 Cr
Revenue (annual)
₹200.7 Cr
Net profit (annual)
₹17.10 Cr
P/E (TTM)
12.0×Sector 46.1×
Promoter holding
63.49%
FII holding
0.77%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Sat Kartar Life Ltd

All →